Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maintenance Lenalidomide After ASCT in High Risk Lymphoma
NCT01575860Phase 2Completed
- Sponsor
- Abramson Cancer Center
- Start
- Apr 2012
- Primary completion
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lenalidomide in lymphoma, sponsored by Abramson Cancer Center. Started Apr 2012; status: completed.
02
Drugs
lenalidomide
03
Conditions
lymphoma
Beyond the preview
Go deeper on NCT01575860.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01575860.